期刊文献+

依诺沙星眼用缓释凝胶剂的体外研究 被引量:6

Study on enoxacin sustained-release ophtfaabnic gel in vitro
下载PDF
导出
摘要 目的 研究依诺沙星眼用缓释凝胶剂。方法 建立UV法测定制剂的含量及体外释药量,建立HPLC测定制剂离体角膜渗透量,采用溶出度法进行处方的体外释药试验,应用离体角膜进行体外渗透试验。结果 亲水凝胶材料含量越小,依诺沙星从凝胶基质中释放越快,体外释药符合一级释放动力学方程;亲水凝胶含量高,体外释放符合Higuchi方程;离体角膜渗透行为符合零级释放规律。结论 依诺沙星眼用凝胶达到了缓慢释放的目的。 OBJECTIVE: To study enoxacin sustained-release ophthalmic gel. METHODS: The release test of formulation was conducted with permeable membrane. The content and the release amount of enoxacin from gel base were determined by UV. The cornea permeation test of formulation was studied with rabbit corneas. The permeant amount of enoxacin was determined by high performance liquid chromatography. RESULTS: The formulation release behavior in vitro followed the first-order kinetic equation with the less amount of polymer (2.0% & 3.0%) in the formulation; otherwise, it followed Higuchi equation with the higher amount of polyer (4.0%) in the formulation. The permeability of enoxacin was raised significantly with the less amount of polyer in the formulation. The formulation permeation behavior in vitro followed the zero-order kinetic equation. CONCLUSION: The release time of enoxacin ophthalmic gel-forming solution was longer than that of eye-drops.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2004年第11期834-836,共3页 Chinese Pharmaceutical Journal
关键词 依诺沙星 凝胶剂 体外释放 离体角膜渗透 Controlled drug delivery Gas permeable membranes Gels High performance liquid chromatography Organic polymers Ultraviolet radiation Vision
  • 相关文献

参考文献9

  • 1Pheyer U, Miliani SK, Dukes A, et al. Effect of topical applied antiCD4 nomoclonal antibodies on orthotopical corneal allografts in rate model[J]. Inwest Ophthalmol Vis Sci,1995,36(1): 52.
  • 2Pekka J, Krisrinna J,Arto U, et al. The use of cyclodextrins in ophthalmic formulation of dipivefrinn[J]. Inter J Pharm, 1997, 153(2):225.
  • 3Durrani AM, Farr SL, Kellaway IW. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in rabbit[J]. Inter J Pharm, 1995,118(2) :243.
  • 4Marchal-Heusler L, Maincent P, Hoffman M, et al. Antiglaucomatous activity of betaxolos chlorhydrate sorbed onto different isobtylcyanoacrylate nanoparticals preparations[J]. Inter J Pharm, 1996,138(2):115.
  • 5Durrani AM, Farr SL, Kellaway IW. Precorneal clearance of mucoadhenseive microsphere from the rabbit eye[J]. J Pharm Pharmacol,1995,47(7) :581.
  • 6Lin HR,Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery[J]. J Cont Rel, 2000(69) :379.
  • 7Rojanasakul Y, Robinson JR. Transport mechanisms of the cornea:characterization of barrier permselectivity[J]. Int J Pharm, 1989,55:237.
  • 8Foroutan SM, Watson DG.The in vitro evaluation of polyethylene glycol esters of hydrocortisone 21-succinate as ocular prodrugs[J]. Iht J Pharm, 1999,182(2) :79.
  • 9Forrester JV, Dick AD, Micmenamin P, et al. The eye basic sciences in practice[M]. London: W.B. Saumders, 1996:137.

同被引文献43

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部